Holen Sie sich die Stockscreener-App
3.68
3.66%
-0.14
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Royce & Associates LP Has $5.06 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
MRVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Maravai Lifesciences Charts Early Turnaround in 2025 - TipRanks
Maravai LifeSciences (NASDAQ:MRVI) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpStill a Buy? - MarketBeat
Is Maravai LifeSciences Holdings Inc.’s ROE strong enoughMarket Growth Report & Fast Exit and Entry Trade Guides - mfd.ru
Maravai Q4 2025 slides: return to positive EBITDA on cost cuts - Investing.com Nigeria
Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada
Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives - Sahm
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace
Maravai LifeSciences Q4 Earnings Call Highlights - MarketBeat
Maravai LifeSciences Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-02-26 - Seeking Alpha
Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call H - GuruFocus
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Maravai Q4 2025 slides: return to positive EBITDA on cost cuts By Investing.com - Investing.com South Africa
Earnings call transcript: Maravai Lifesciences Q4 2025 beats EPS forecast, stock jumps 4.5% - Investing.com Canada
MRVI: 2025 saw revenue beat, margin recovery, and strong 2026 growth and profitability guidance - TradingView
Maravai LifeSciences Holdings Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Maravai LifeSciences (NASDAQ:MRVI) Issues Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
MRVI Projects FY26 Adjusted EBITDA Between $18M and $20M - GuruFocus
Maravai LifeSciences (MRVI) Surpasses Revenue Expectations in Q4 - GuruFocus
Maravai LifeSciences (NASDAQ: MRVI) posts 2025 loss but targets 2026 EBITDA rebound - Stock Titan
Maravai LifeSciences Q4 2025 Earnings Call Transcript - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
What are Maravai LifeSciences Holdings Inc.’s growth levers2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Maravai LifeSciences Holdings, Inc. $MRVI Shares Bought by Monaco Asset Management SAM - MarketBeat
Value Recap: What is the PEG ratio of Maravai LifeSciences Holdings IncEarnings Overview Report & Daily Entry Point Alerts - baoquankhu1.vn
Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating a 27.55% Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stock Traders Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (MRVI) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
12 West Capital (NASDAQ: MRVI) discloses 6.2% beneficial stake in Maravai - Stock Titan
Is There An Opportunity With Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 34% Undervaluation? - Yahoo Finance
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of "Hold" by Brokerages - MarketBeat
MRVI Should I Buy - Intellectia AI
Market Moves: Will REFI face regulatory challengesWeekly Investment Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Investor group (NASDAQ: MRVI) reports 7.23% Maravai LifeSciences stake - Stock Titan
Options Flow: Will Cohen Company Inc face regulatory challengesQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn
Gainers Report: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Buyback Activity & Smart Swing Trading Techniques - baoquankhu1.vn
Maravai to Announce Q4 and Full Year 2025 Results - Intellectia AI
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Business Wire
What MACD trends signal for Maravai LifeSciences Holdings Inc. (MAR) stockQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect - ACCESS Newswire
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - MarketBeat
Volume Report: How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Tejara Capital Ltd Has $7.04 Million Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Stock Analysis: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):